Physician profile
Milton Jackson
NPI 1437198546
$624.59
in general payments reported to CMS, 2019-2025
17 companies · $21.26 in 2025
The $21.26 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9.11 · 2021: $88.45 · 2023: $230 · 2024: $276 · 2025: $21.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $130.86 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Merz North America, INC. | $88.45 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $79.87 | 2023-2024 | Airsupra |
| Lilly USA, LLC | $41.33 | 2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $40.61 | 2023 | Pneumovax 23, Gardasil 9, Vaxneuvance |
| Axsome Therapeutics, INC. | $29.03 | 2024 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $25.86 | 2023 | |
| Pfizer INC. | $25.05 | 2024 | |
| Phathom Pharmaceuticals, INC. | $23.62 | 2024 | Voquezna |
| Sanofi Pasteur INC. | $21.96 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.30 | 2024 | Xifaxan |
| Abbvie INC. | $21.26 | 2025 | |
| Hologic Sales and Service, LLC | $18.82 | 2023 | Aptima |
| Novartis Pharmaceuticals Corporation | $17.02 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.75 | 2024 | Caplyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.69 | 2023 | Otezla, Repatha |
| Sunovion Pharmaceuticals INC. | $9.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milton Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.